Search - tctmd.com

Displaying 41 - 60 of 2378

Sort: Relevancy | Date

Presentation TCT 2025

What can CDT Accomplish that MT Can’t Do Faster?

Presenter: Michael Young

October 27, 2025

Presentation TCT 2025

Initial, Prospective Analysis of Uncontrolled Hypertensive Patients Included in the Global Paradise System (GPS) Registry Outside of the United States

Presenter: Karl Fengler

October 27, 2025

Presentation TCT 2025

First Report of the SPYRAL AFFIRM Study: Reduced Home and Office Blood Pressure Following Radiofrequency Renal Denervation in a Large US Cohort of High Cardiovascular Risk Patients.

Presenter: Felix Mahfoud

October 27, 2025

Presentation TCT 2025

Pipeline Devices for HTN

Presenter: Lucas Lauder

October 27, 2025

Presentation TCT 2025

On-Table Predictors of Successful Denervation - Where are We in 2025?

Presenter: Felix Mahfoud

October 27, 2025

Presentation TCT 2025

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

Presenter: David P. Lee

October 27, 2025

Presentation TCT 2025

Where Do We See Renal Denervation in the Hypertension Pathway, Now and in Five Years?

Presenter: David E. Kandzari

October 27, 2025

Presentation TCT 2025

TCT 911: A Novel Automated and Portable Carbon Dioxide Angiographic Injector for Peripheral Endovascular Therapies in Patients at High Risk of Iodinated Contrast Media

Presenter: Yuxian Luo

October 27, 2025

Presentation TCT 2025

TCT 913: Clinical Impact of Endovascular Therapy with Percutaneous Fogarty Thrombectomy for Acute Limb Ischemia

Presenter: Eiji Koyama

October 27, 2025

Presentation TCT 2025

The Gift and the Curse: A Young Physician’s Journey Revitalizing Rural CLTI Vascular Care

Presenter: Tara Holder

October 27, 2025

Presentation TCT 2025

Multi-societal “Get a Pulse on PAD” Campaign: What We’ve Learned and the Impact So Far

Presenter: Laurie Mobley

October 27, 2025

Presentation TCT 2025

Emerging Therapies: The Role of GLP-1 Agonists and SGLT2 Inhibitors in PAD/CLTI Management. Impact on the Guidelines

Presenter: Marc P. Bonaca

October 27, 2025

Presentation TCT 2025

Acute Aortic Syndromes: Who’s Going to do Them?

Presenter: Jason T. Lee

October 27, 2025

Presentation TCT 2025

Pulmonary Embolism – Do We Have the Right Workforce?

Presenter: Kenneth Rosenfield

October 27, 2025

Presentation TCT 2025

Workforce Challenges in Stroke Care

Presenter: J Mocco

October 27, 2025

Presentation TCT 2025

CLTI Care & Disparities

Presenter: Foluso Fakorede

October 27, 2025

Presentation TCT 2025

Global Workforce Challenges for Vascular Disease

Presenter: Robert A. Lookstein

October 27, 2025

Presentation TCT 2025

TCT 1750: Endovascular Treatment for Concomitant Ischemic Stroke and ST Elevation Myocardial Infarction in a Single Procedure

Presenter: ShihWei Meng

October 27, 2025

Presentation TCT 2025

Case 3: When and How to Perform ECMO Supported PE Intervention

Presenter: Jay S. Giri

October 27, 2025

Presentation TCT 2025

Case 2: When is Enough Enough? How to Decide When to Stop in Catheter Thrombectomy?

Presenter: Catalin Toma

October 27, 2025

Advertisement

What can CDT Accomplish that MT Can’t Do Faster?

Initial, Prospective Analysis of Uncontrolled Hypertensive Patients Included in the Global Paradise System (GPS) Registry Outside of the United States

First Report of the SPYRAL AFFIRM Study: Reduced Home and Office Blood Pressure Following Radiofrequency Renal Denervation in a Large US Cohort of High Cardiovascular Risk Patients.

Pipeline Devices for HTN

On-Table Predictors of Successful Denervation - Where are We in 2025?

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

Where Do We See Renal Denervation in the Hypertension Pathway, Now and in Five Years?

TCT 911: A Novel Automated and Portable Carbon Dioxide Angiographic Injector for Peripheral Endovascular Therapies in Patients at High Risk of Iodinated Contrast Media

TCT 913: Clinical Impact of Endovascular Therapy with Percutaneous Fogarty Thrombectomy for Acute Limb Ischemia

The Gift and the Curse: A Young Physician’s Journey Revitalizing Rural CLTI Vascular Care

Multi-societal “Get a Pulse on PAD” Campaign: What We’ve Learned and the Impact So Far

Emerging Therapies: The Role of GLP-1 Agonists and SGLT2 Inhibitors in PAD/CLTI Management. Impact on the Guidelines

Acute Aortic Syndromes: Who’s Going to do Them?

Pulmonary Embolism – Do We Have the Right Workforce?

Workforce Challenges in Stroke Care

CLTI Care & Disparities

Global Workforce Challenges for Vascular Disease

TCT 1750: Endovascular Treatment for Concomitant Ischemic Stroke and ST Elevation Myocardial Infarction in a Single Procedure

Case 3: When and How to Perform ECMO Supported PE Intervention

Case 2: When is Enough Enough? How to Decide When to Stop in Catheter Thrombectomy?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content